Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation

May 1, 2013, 00:00
10.1016/j.jval.2013.03.1483
https://www.valueinhealthjournal.com/article/S1098-3015(13)01554-4/fulltext
Title : Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01554-4&doi=10.1016/j.jval.2013.03.1483
First page : A286
Section Title : Cardiovascular Disorders
Open access? : No
Section Order : 1053
Categories :
Tags :
Regions :
ViH Article Tags :